Dr Reddy’s Laboratories Ltd. denied plans to implement a 25% workforce price discount via an alternate submitting on posted on NSE.
The pharmaceutical producer deemed the information of its plans to cut back workforce prices by 25% by way of main layoff initiatives, to be “factually incorrect”.
Saying that they “categorically deny” the declare which was first revealed in Enterprise Commonplace’s information article ‘DRL Trims Workforce Prices By 25% Amid Revlimid-Linked Margin Pressure’.
“On this regard, please notice that the corporate doesn’t touch upon market speculations and there may be presently no such occasion or info which requires a disclosure,” the agency mentioned in its alternate submitting.
